Elypta Announces Urine Biomarker Study Demonstrating Improved Five-Year Cancer Risk Prediction in 5,436 Adults
Pre-specified high-risk group held 54% of cancers over five years STOCKHOLM, Nov. 11, 2026 /PRNewswire/ -- A urine profile of three glycosaminoglycan disacharrides (GAGs) predicted five-year cancer risk in healthy adults, according to a peer-reviewed study published in Cancer...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.